Aveanna Healthcare (NASDAQ:AVAH) Major Shareholder Sells $166,750,023.00 in Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAHGet Free Report) major shareholder Robert Williams, Jr. sold 14,500,002 shares of Aveanna Healthcare stock in a transaction that occurred on Thursday, August 20th. The shares were sold at an average price of $11.50, for a total value of $166,750,023.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Large shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

Aveanna Healthcare Stock Performance

AVAH stock opened at $13.62 on Thursday. The company has a debt-to-equity ratio of 4.47, a quick ratio of 1.16 and a current ratio of 1.16. The stock has a market capitalization of $2.97 billion, a price-to-earnings ratio of 11.07, a PEG ratio of 0.85 and a beta of 1.90. Aveanna Healthcare Holdings Inc. has a 1 year low of $5.93 and a 1 year high of $13.98. The stock’s fifty day moving average is $9.95 and its two-hundred day moving average is $8.03.

Aveanna Healthcare (NASDAQ:AVAHGet Free Report) last released its quarterly earnings results on Thursday, August 13th. The company reported $0.22 EPS for the quarter, topping the consensus estimate of $0.17 by $0.05. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. The business had revenue of $670.48 million during the quarter, compared to analyst estimates of $638.61 million. On average, research analysts predict that Aveanna Healthcare Holdings Inc. will post 0.75 EPS for the current year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of AVAH. Caitong International Asset Management Co. Ltd grew its holdings in Aveanna Healthcare by 252.4% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock worth $27,000 after acquiring an additional 2,400 shares during the period. Quantbot Technologies LP acquired a new stake in Aveanna Healthcare in the 2nd quarter valued at about $43,000. Summit Securities Group LLC acquired a new stake in Aveanna Healthcare in the 1st quarter valued at about $53,000. Oxford Asset Management LLP bought a new position in shares of Aveanna Healthcare during the 2nd quarter valued at about $64,000. Finally, C M Bidwell & Associates Ltd. bought a new position in shares of Aveanna Healthcare during the 2nd quarter valued at about $69,000. Institutional investors own 87.96% of the company’s stock.

Analyst Ratings Changes

Several research firms have commented on AVAH. UBS Group upped their target price on shares of Aveanna Healthcare from $8.00 to $13.00 and gave the stock a “neutral” rating in a research report on Friday, August 14th. Truist Financial boosted their price objective on Aveanna Healthcare from $11.00 to $15.00 and gave the stock a “hold” rating in a research report on Monday. Raymond James Financial boosted their price objective on Aveanna Healthcare from $13.00 to $15.00 and gave the stock a “strong-buy” rating in a research report on Friday, August 14th. BMO Capital Markets increased their price objective on Aveanna Healthcare from $10.00 to $14.00 and gave the stock an “outperform” rating in a report on Friday, August 14th. Finally, Barclays raised their target price on Aveanna Healthcare from $9.00 to $9.50 and gave the company an “overweight” rating in a research report on Thursday, July 9th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $12.89.

Read Our Latest Stock Report on AVAH

About Aveanna Healthcare

(Get Free Report)

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.

Further Reading

Insider Buying and Selling by Quarter for Aveanna Healthcare (NASDAQ:AVAH)

Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.